Author/Creator: Moore, Kenneth Todd - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Moore, Kenneth Todd

1. A Cross‐Study Analysis Evaluating the Effects of Food on the Pharmacokinetics of Rivaroxaban in Clinical Studies. (5th July 2017)

Authors:: Zhang, Liping; Peters, Gary; Haskell, Lloyd; Patel, Purve; Nandy, Partha; Moore, Kenneth Todd
Journal:: Journal of clinical pharmacology
Issue:: Volume 57:Number 12(2017)
Page Start:: 1607
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data. (2nd July 2020)

Authors:: Costa, Olivia S.; Beyer-Westendorf, Jan; Ashton, Veronica; Milentijevic, Dejan; Moore, Kenneth Todd; Bunz, Thomas J.; Coleman, Craig I.
Journal:: Current medical research and opinion
Issue:: Volume 36:Number 7(2020)
Page Start:: 1081
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population. (1st January 2021)

Authors:: Berger, Jeffrey S.; Laliberté, François; Kharat, Akshay; Lejeune, Dominique; Moore, Kenneth Todd; Jung, Young; Lefebvre, Patrick; Ashton, Veronica
Journal:: Journal of medical economics
Issue:: Volume 24:Number 1(2021)
Page Start:: 550
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population. (3rd June 2021)

Authors:: Berger, Jeffrey S.; Laliberté, François; Kharat, Akshay; Lejeune, Dominique; Moore, Kenneth Todd; Jung, Young; Lefebvre, Patrick; Ashton, Veronica
Journal:: Current medical research and opinion
Issue:: Volume 37:Number 6(2021)
Page Start:: 881
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis. (20th October 2020)

Authors:: Costa, Olivia S.; Beyer-Westendorf, Jan; Ashton, Veronica; Milentijevic, Dejan; Moore, Kenneth Todd; Bunz, Thomas J.; Coleman, Craig I.
Journal:: Clinical and applied thrombosis/hemostasis
Issue:: Volume 26(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects. (June 2015)

Authors:: Moore, Kenneth Todd; Byra, William; Vaidyanathan, Seema; Natarajan, Jaya; Ariyawansa, Jay; Salih, Hiba; Turner, Kenneth C.
Journal:: British journal of clinical pharmacology
Issue:: Volume 79:Number 6(2015:Jun.)
Page Start:: 907
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗